Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glial Cells01:04

Glial Cells

Overview
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous heart rate variability monitoring, stress and recovery in doctors: a systematic review and meta-analysis.

Occupational medicine (Oxford, England)·2025
Same author

How to spot the recurring lumbar disc? Risk factors for recurrent lumbar disc herniation (rLDH) in adult patients with lumbar disc prolapse: a systematic review and meta-analysis.

Acta orthopaedica Belgica·2023
Same author

Protecting retinal ganglion cells.

Eye (London, England)·2017
Same author

Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism.

Cell death & disease·2016
Same author

Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.

The Journal of urology·2011
Same author

Broadening our focus in the search for cell transplantation-based glaucoma therapies.

Eye (London, England)·2011

Related Experiment Video

Updated: Jun 28, 2026

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
09:46

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

Published on: July 15, 2025

Stem cells for neuroprotection in glaucoma.

N D Bull1, T V Johnson, K R Martin

  • 1Cambridge Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 2PY, UK.

Progress in Brain Research
|October 22, 2008
PubMed
Summary

Stem cell transplantation shows promise for treating neurodegenerative diseases like glaucoma. This therapy offers potential chronic neuroprotection and targeted treatment delivery within the central nervous system (CNS).

More Related Videos

Primary Cell Cultures to Study the Regeneration Potential of Murine Müller Glia after MicroRNA Treatment
10:16

Primary Cell Cultures to Study the Regeneration Potential of Murine Müller Glia after MicroRNA Treatment

Published on: March 28, 2022

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Related Experiment Videos

Last Updated: Jun 28, 2026

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
09:46

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

Published on: July 15, 2025

Primary Cell Cultures to Study the Regeneration Potential of Murine Müller Glia after MicroRNA Treatment
10:16

Primary Cell Cultures to Study the Regeneration Potential of Murine Müller Glia after MicroRNA Treatment

Published on: March 28, 2022

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Ophthalmology

Background:

  • Neurodegenerative diseases, including glaucoma, represent a significant unmet medical need.
  • Current treatments for neurodegenerative diseases often focus on symptom management rather than disease modification.
  • Stem cell transplantation is emerging as a potential disease-modifying therapy.

Purpose of the Study:

  • To explore the potential of stem cell transplantation as a therapeutic strategy for neurodegenerative diseases, with a focus on glaucoma.
  • To investigate the mechanisms by which stem cells may offer neuroprotection and facilitate endogenous repair in the central nervous system (CNS).
  • To assess the feasibility and efficacy of stem cell-based therapies in preclinical models.

Main Methods:

  • Review of existing literature on stem cell transplantation in neurodegenerative disease models.
  • Analysis of potential stem cell sources, including embryonic, fetal, and adult-derived cells.
  • Examination of proposed neuroprotective mechanisms, such as neurotrophic factor supply and modulation of the CNS environment.

Main Results:

  • Early results in models of spinal cord injury and Parkinson's disease show encouraging neuroprotection.
  • Stem cells demonstrate the ability to accumulate at CNS injury sites and enable targeted treatment delivery.
  • Adult-derived stem cells may become preferred over embryonic and fetal sources with improved modification techniques.

Conclusions:

  • Stem cell transplantation is a promising therapeutic approach for glaucoma and other neurodegenerative diseases.
  • Further research and overcoming existing challenges are necessary for clinical translation.
  • Stem cell research in glaucoma may yield insights applicable to a broader range of CNS disorders.